We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Rite Aid Corp | NYSE:RAD | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.6483 | 0 | 01:00:00 |
By Michael Calia
Rite Aid Corp. on Thursday said sales at stores open at least a year grew 4.8% for the four weeks ended Jan. 24, with pharmacy-sales growth outpacing growth in the front end.
For the four-week period, Rite Aid said total drugstore sales rose 4.3% to $1.94 billion.
The pharmacy business reported a 5.7% rise in same-store sales, which included negative impact of 1.14 percentage points stemming from new generic drugs. The prescription count rose 3.5%.
Front-end sales rose 2.9%, Rite Aid said.
The results mark a decrease from the company's sales figures in December, when it posted 5.3% same-store sales growth and 4.9% growth in overall drugstore sales.
Rite Aid, the nation's No. 3 drugstore chain, reported its sales for January more than a week after rival Walgreens Boots Alliance Inc. said it would cease issuing monthly sales reports. Instead, the company will opt to explain its performance in quarterly reports.
Write to Michael Calia at michael.calia@wsj.com
Access Investor Kit for Rite-Aid Corp.
Visit http://www.companyspotlight.com/partner?cp_code=P479&isin=US7677541044
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Rite Aid Chart |
1 Month Rite Aid Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions